ANTIBIOTIC RESISTANCE PATTERNS OF BACTERIAL ISOLATES IN ENT INFECTIONS: A TERTIARY CARE HOSPITAL–BASED CROSS-SECTIONAL STUDY FROM NORTH INDIA
Main Article Content
Keywords
Antibiotic resistance; ENT infections; multidrug resistance; Staphylococcus aureus; Pseudomonas aeruginosa; antimicrobial susceptibility; North India.
Abstract
Background:Antimicrobial resistance is an escalating global health concern, significantly affecting the management of ear, nose, and throat (ENT) infections. Empirical antibiotic therapy without culture guidance has contributed to increasing resistance among common ENT pathogens, particularly in developing countries.
Objectives:To determine the bacterial profile and antibiotic resistance patterns of isolates obtained from patients with ENT infections in a tertiary care hospital in North India.
Methods:A hospital-based cross-sectional study was conducted from March 2022 to August 2022. A total of 166 bacterial isolates obtained from clinically diagnosed ENT infections were included. Specimens were processed using standard microbiological techniques, and antimicrobial susceptibility testing was performed using the Kirby–Bauer disc diffusion method in accordance with CLSI guidelines. Data were analyzed using SPSS version 22.0, and results were expressed in frequency and percentage.
Results:Among 166 isolates, chronic suppurative otitis media was the most common infection (34.9%). Staphylococcus aureus(32.5%) was the predominant organism, followed by Pseudomonas aeruginosa (24.7%) and Klebsiella pneumoniae(16.9%). High resistance was observed to ampicillin (71.0% in Gram-positive and 78.3% in Gram-negative isolates) and erythromycin (63.8%). Third-generation cephalosporins also showed considerable resistance (62.8% in Gram-negative isolates). Lower resistance was noted for vancomycin, linezolid, piperacillin-tazobactam, and carbapenems. Overall, 41.0% of isolates were multidrug resistant.
Conclusion:ENT infections in this tertiary care setting show a high prevalence of multidrug-resistant organisms, limiting the effectiveness of commonly used antibiotics. Regular surveillance of antimicrobial susceptibility patterns and implementation of antibiotic stewardship programs are essential to guide rational therapy and reduce the burden of resistance.
References
2. Mendelson M, Matsoso MP. The World Health Organization global action plan for antimicrobial resistance. SAMJ: South African Medical Journal. 2015 May;105(5):325-9.
3. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C. Antibiotic resistance—the need for global solutions. The Lancet infectious diseases. 2013 Dec 1;13(12):1057-98.
4. Rosenfeld RM, Schwartz SR, Cannon CR, Roland PS, Simon GR, Kumar KA, Huang WW, Haskell HW, Robertson PJ. Clinical practice guideline: acute otitis externa. Otolaryngology–Head and Neck Surgery. 2014 Feb;150:S1-24.
5. Brook I. Anaerobic infections: diagnosis and management. CRC Press; 2007 Sep 26.
6. Casey JR. Treatment of AOM Post-PCV7: Judicious Antibiotic Therapy. Contemporary Pediatrics. 2005 Dec 2;22.
7. Khan DR, Sharma DV, Khan DS, Rasool DS, Singh S, Rai AK, Rustagi S, Shreaz S, Negi R, Kour D, Yadav AN. Prevention and Potential Remedies for Antibiotic Resistance: Current Research and Future Challenges. Available at SSRN 4647883.
8. Ponnusankar S. Need for the implementation of antibiotic policy in India: An Overview. Int J Cur Res Rev| Vol. 2021 Mar;13(05):168.
9. Prah JK. TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH.
10. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist BJ, Paterson DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection. 2012 Mar 1;18(3):268-81.
11. Brook I. The role of anaerobic bacteria in chronic suppurative otitis media in children: implications for medical therapy. Anaerobe. 2008 Dec 1;14(6):297-300.
12. Mittal R, Lisi CV, Gerring R, Mittal J, Mathee K, Narasimhan G, Azad RK, Yao Q, Grati MH, Yan D, Eshraghi AA. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media. Journal of medical microbiology. 2015 Oct;64(10):1103-16.
13. Kaul M, Kaur S, Wadhwa S, Chhibber S. Microbial contamination of weaning foods. The Indian Journal of Pediatrics. 1996 Jan;63(1):79-85.
14. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clinical microbiology reviews. 2005 Oct;18(4):657-86.
15. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerging infectious diseases. 2011 Oct;17(10):1791.
16. Shaik G, Sujatha N, Mehar SK. Medicinal plants as source of antibacterial agents to counter Klebsiella pneumoniae. Journal of Applied Pharmaceutical Science. 2014 Jan 30;4(1):135-47.

